vTv Therapeutics Inc Cash Flow-to-Debt Ratio
vTv Therapeutics Inc cash flow-to-debt ratio. vTv Therapeutics Inc (VTVT) has a Cash Flow-to-Debt Ratio of -0.26x as of June 2026, meaning its operating cash flow of $-2.29 Million could theoretically repay 0% of its total liabilities ($8.96 Million) in one year. Check vTv Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of vTv Therapeutics Inc (2013–2025)
Cash flow-to-debt ratio of vTv Therapeutics Inc from 2013 to 2025. Historical debt coverage capacity for vTv Therapeutics Inc across 13 annual periods. Check vTv Therapeutics Inc (VTVT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
vTv Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
vTv Therapeutics Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for vTv Therapeutics Inc. For the full cash flow conversion analysis, see vTv Therapeutics Inc (VTVT) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.99x | $-25.25 Million | $25.46 Million | ▲ +6.1% |
| 2024 | -1.06x | $-25.31 Million | $23.96 Million | ▼ -63.6% |
| 2023 | -0.65x | $-19.08 Million | $29.57 Million | ▼ -16.0% |
| 2022 | -0.56x | $-15.25 Million | $27.40 Million | ▲ +70.5% |
| 2021 | -1.88x | $-19.31 Million | $10.25 Million | ▼ -15.1% |
| 2020 | -1.64x | $-18.00 Million | $11.00 Million | ▼ -28.8% |
| 2019 | -1.27x | $-23.02 Million | $18.11 Million | ▼ -332.7% |
| 2018 | -0.29x | $-26.86 Million | $91.41 Million | ▼ -18.0% |
| 2017 | -0.25x | $-44.56 Million | $178.96 Million | ▲ +24.9% |
| 2016 | -0.33x | $-48.21 Million | $145.44 Million | ▼ -52.1% |
| 2015 | -0.22x | $-36.95 Million | $169.50 Million | ▼ -262.4% |
| 2014 | -0.06x | $-30.78 Million | $511.76 Million | ▲ +53.9% |
| 2013 | -0.13x | $-41.68 Million | $319.24 Million | — |